Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
RESEARCH TOOLSreports
Holding AU:NEU?
Track your performance easily
See the Price Targets and Ratings of:
NEU Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NEU Stock 12 Month Forecast
Average Price Target
AU$28.82
▲(137.36% Upside)
| Highest Price TargetAU$30.94 | Average Price TargetAU$28.82 | Lowest Price TargetAU$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wilsons
Reiterated
11/08/24
Canaccord Genuity
Reiterated
11/07/24
Jefferies
Reiterated
11/06/24
Bell Potter
Reiterated
08/28/24
J.P. Morgan
AU$26.7→AU$23
Buy
89.46%
Upside
Reiterated
08/12/24
Neuren Pharmaceuticals Ltd (NEU:AU) PT Lowered to AUD22 at JPMorganJPMorgan analyst Silvia Luo lowered the price target on Neuren Pharmaceuticals Ltd (NEU:AU) to AUD22.00 (from AUD26.70) while maintaining a Overweight rating.
Best Analysts Covering Neuren Pharmaceuticals Limited
Which Analyst Should I Follow If I Want to Buy AU:NEU and Sell After:
1 Month
xxx
Success Rate
5/7 ratings generated profit
Average Return
-2.26%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of -2.26% per trade.
3 Months
xxx
Success Rate
6/12 ratings generated profit
Average Return
+7.15%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.15% per trade.
1 Year
Success Rate
8/12 ratings generated profit
Average Return
+19.44%
reiterated a buy rating 14 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +19.44% per trade.
2 Years
xxx
Success Rate
7/12 ratings generated profit
Average Return
+2.27%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of +2.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NEU Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
8
10
10
9
4
Buy
0
1
1
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
11
11
11
5
Each month's total comprises the sum of three months' worth of ratings.
NEU Financial Forecast
NEU Stock Forecast FAQ
What is AU:NEU’s average 12-month price target, according to analysts?
Based on analyst ratings, Neuren Pharmaceuticals Limited’s 12-month average price target is AU$28.82.
What is AU:NEU’s upside potential, based on the analysts’ average price target?
Neuren Pharmaceuticals Limited has 137.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Neuren Pharmaceuticals Limited a Buy, Sell or Hold?
Neuren Pharmaceuticals Limited has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Neuren Pharmaceuticals Limited’s share price target?
The average share price target for Neuren Pharmaceuticals Limited is AU$28.82. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$30.94 ,and the lowest forecast is AU$25.00. The average share price target represents 137.36% Increase from the current price of AU$12.14.
The highest analyst share price target is AU$30.94 ,and the lowest forecast is AU$25.00. The average share price target represents 137.36% Increase from the current price of AU$12.14.
What do analysts say about Neuren Pharmaceuticals Limited?
Neuren Pharmaceuticals Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Neuren Pharmaceuticals Limited?
To buy shares of AU:NEU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.